Published ahead of print on May 15, 2008, doi:10.1165/rcmb.2007-0325OC
© 2008 American Thoracic Society DOI: 10.1165/rcmb.2007-0325OC Nasal Epithelial Cells as Surrogates for Bronchial Epithelial Cells in Airway Inflammation Studies1 School of Medicine, University of Aberdeen; 2 Department of Respiratory Medicine, Aberdeen Royal Infirmary; and 3 Department of Medical Paediatrics, Royal Aberdeen Children's Hospital, Aberdeen, United Kingdom Correspondence and requests for reprints should be addressed to Catherine McDougall, MRCPCH, PhD, Department of Child Health, University of Aberdeen, Royal Aberdeen Children's Hospital, Westburn Road, Aberdeen AB25 2ZG, UK. E-mail: catherine.mcdougall{at}luht.scot.nhs.uk
The nose is an attractive source of airway epithelial cells, particularly in populations in which bronchoscopy may not be possible. However, substituting nasal cells for bronchial epithelial cells in the study of airway inflammation depends upon comparability of responses, and evidence for this is lacking. Our objective was to determine whether nasal epithelial cell inflammatory mediator release and receptor expression reflect those of bronchial epithelial cells. Paired cultures of undifferentiated nasal and bronchial epithelial cells were obtained from brushings from 35 subjects, including 5 children. Cells were subject to morphologic and immunocytochemical assessment. Mediator release from resting and cytokine-stimulated cell monolayers was determined, as was cell surface receptor expression. Nasal and bronchial cells had identical epithelial morphology and uniform expression of cytokeratin 19. There were no differences in constitutive expression of CD44, intercellular adhesion molecule-1,
Key Words: airway epithelium cultured cells mediator release adult child
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||